Resource Tag: Medication Assisted Treatment

Medication assisted treatment
Methandone
Buprenorphine
Naltrexone
Vivitrol
Opioid treatment program (OTP)
Office based opioid treatment (OBOT)
Drug Addiction Treatment Act (DATA) waiver

Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System

This discussion paper from researchers affiliated with the National Academy of Medicine identifies strategies to increase access to evidence-based treatment for opioid use disorder (OUD) in health care settings. Effective OUD treatment includes access to medications such as methadone, buprenorphine, or extended-release naltrexone as well as opportunities to receive additional services such as behavioral counseling, case management, and peer support. Continue reading →

Opioid Use Disorder: Barriers to Medicaid Beneficiaries’ Access to Treatment Medications

The U.S. Department of Health and Human Services has prioritized expanding access to medication assisted treatment (MAT) for opioid use disorder (OUD) as an evidence-based treatment. Because many individuals with OUD are Medicaid beneficiaries, this U.S. Governmental Accountability Office report looked at state Medicaid policies and state and federal laws that might act as a barrier to Medicaid patients accessing MAT. Continue reading →

Get Waivered

A link to the Get Waivered website which helps clinicians obtain Drug Enforcement Administration -X waivers to prescribe buprenorphine for opioid use disorder (OUD). They provide free waiver training as well as support for creating buprenorphine programs in emergency departments and strategies from the field of behavioral economics to help departments adopt new practices to treat OUD. Continue reading →

Applying the Evidence: Legal and Policy Approaches to Address Opioid Use Disorder in the Criminal Justice and Child Welfare Settings

A comprehensive report on increasing access to evidence-based treatments for substance use disorder in the criminal justice and child welfare systems from researchers at the Addiction & Public Policy Initiative of the O’Neill Institute for National and Global Health Law at Georgetown Law Center. The report specifically addresses increasing access to medications to treat opioid use disorder (MOUD) in jails and prisons, in treatment court settings, and in the child welfare system. The report reviews programs in multiple states and summarizes legal, legislative and fiscal strategies to implement and manage evidence-based, public-health focused interventions in these settings. Continue reading →

Medication-Assisted Treatment and Other Behavioral Interventions for Opioid Use Disorder: Evidence, Guidelines, Policies, and Service Delivery Models – Rapid Review

This 2019 systematic review assesses the evidence for the effectiveness of behavioral health interventions as part of a medication-assisted treatment (MAT) regimen for opioid use disorder (OUD). The report also evaluates clinical practice guideline recommendations for behavioral health treatments as a part of MAT and describes 3 service delivery models that implement low-threshold MAT programs in Missouri, Virginia and in the Veterans Health Administration. Continue reading →

COVID-19

The COVID-19 public health emergency is particularly challenging for people in treatment for substance use disorder, people in recovery, and people who use drugs. This collection features educational resources that can be adapted for local settings, specific guidance on harm reduction, recovery housing and providing peer support services during the pandemic, and links to websites that provide high-quality information, data, and/or examples for local communities to adopt. Continue reading →